Liver function information plays an important role in the decision-making of treatment strategy in liver cirrhosis and in the prevention of liver failure after treatment. In recent years, more and more evidence of Gd-EOB-DTPA MRI T1mapping can be used to the liver and partial liver function. As cirrhosis often leads to changes in liver-related blood flow, we demonstrate the feasibility of 4D Flow MRI on quantitative assessment of the disease.
This abstract and the presentation materials are available to members only; a login is required.